Sort
8,912 grants matching “sars cov 2”
Project 1: Mechanisms of innate sensing and pathogenesis of SARS-CoV-2
$815,251Andrea L Cox · Johns Hopkins University · U54 · FY2020 · CA
Immunogenetics of COVID-19 Immune Response
$814,873Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2024 · AI
Balancing epithelial cell resistance and resilience to respiratory viral infections
$814,724Jose Manuel Ordovas-Montanes · Boston Children'S Hospital · R01 · FY2024 · HL
Developing Durable, Env-Boosted CAR T Cells for HIV Cure
$814,373Christopher W Peterson · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
Impact of the COVID-19 Pandemic on Patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias
$814,164John Hsu · Massachusetts General Hospital · U01 · FY2024 · AG
Expansion of SARS-CoV-2 Testing Supplement, Chicago Clinical Trials Unit
$814,136Babafemi O Taiwo · Northwestern University At Chicago · UM1 · FY2020 · AI
Determining factors of transmission and evolution of SARS-CoV-2 in populations at risk
$812,851Elodie Ghedin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Long term adverse health outcomes for women and children following SARS-CoV-2 infection during pregnancy
$812,782Monique Marie Hedderson · Kaiser Foundation Research Institute · R01 · FY2025 · AI
SARS-CoV-2 Surveillance Studies and Genome Sequencing in Rural New England
$812,582Michael L Whitfield · Dartmouth College · P20 · FY2021 · GM
Blood DNA Methylation Biomarkers of Post AcuteSequelae of SARS CoV 2 Infection (PASC)
$812,430Adolfo Ariel Jaitovich · Albany Medical College · R01 · FY2023 · AI
Immune response, transmission model, and contact network determinants of disease spread
$812,397Bruce Rogers · Duke University · U54 · FY2025 · AI
Point-of-care prognostic modeling of PTSD risk after traumatic event exposure using digital biomarkers and clinical data from electronic health records in the emergency department setting (PREDICT)
$812,386Katharina Schultebraucks · New York University School Of Medicine · R01 · FY2025 · MH
Impact of SARS-CoV-2 infection on respiratory viral immune responses in children with and without asthma
$812,349Stefan Worgall · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AI
BREATHE - Bridging Research, Lung Health, and the Environment - Children's Center
$812,038Meredith C McCormack · Johns Hopkins University · P2C · FY2023 · ES
SARS-CoV-2 correlates of protection in a Latino-origin population
$812,000Carlos A Sariol · University Of Puerto Rico Med Sciences · U01 · FY2024 · CA
Dissemination and Implementation of COVID-19 Care Innovations in ED Settings
$811,942Peter James Mendel · Rand Corporation · R01 · FY2024 · AI
Assessing functional immunity to influenza infection by quantifying BCR binding avidities
$811,009Steven Carl George · University Of California At Davis · R01 · FY2025 · AI
SARS-CoV-2 correlates of protection in a Latino-origin population
$810,388Carlos A Sariol · University Of Puerto Rico Med Sciences · U01 · FY2022 · CA
Metallothionein 1E as a Central Regulator of Human Pancreatic Beta Cell Function and Survival
$809,857Shuibing Chen · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · DK
Exploring Siglec-glycan ligand interactions using chemoenzymatic approaches
$809,851Peng Wu · Scripps Research Institute, The · R01 · FY2023 · AI
Exploring Siglec-glycan ligand interactions using chemoenzymatic approaches
$809,851Peng Wu · Scripps Research Institute, The · R01 · FY2024 · AI
The role of the microbiome in childhood disease
$809,731Suchitra Hourigan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Discovery and clinical validation of host biomarkers of disease severity and multi-system inflammatory syndrome in children (MIS-C) with Covid-19
$809,678Charles Yen Chiu · University Of California, San Francisco · R61 · FY2022 · HD
MHC Variation in Host Response to SARS-CoV2 and COVID-19 Outcomes
$809,466Jill Allison Hollenbach · University Of California, San Francisco · R01 · FY2021 · AI
ACE2-targeted PET radiotracers for investigating spatiotemporal distribution of SARS-CoV-2 organ injury and therapy response.
$809,270David M Wilson · University Of California, San Francisco · R01 · FY2022 · AI